Opportunities include technological innovation, strategic partnerships, and regional market expansion to enhance operational ...
Lactated Ringers Injection Market to reach USD 2.9 Bn by 2036, driven by rising hospital admissions, increasing surgical ...
Findings challenge prevailing ignition–sustainment assumptions, reframing plasma instability as a systems-level ...
A B.C. company racing to prove its fusion technology says it will combine its business with a special purpose acquisition ...
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed its acquisition of Astria Therapeutics, ...
Enhanced oil recovery (EOR) is a method used to extract oil beyond primary and secondary techniques. Explore different EOR ...
The platform that slashed NASA's R&D costs and compressed three-day computations into one hour is now available to ...
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed its acquisition of Astria Therapeutics, Inc., initially ...
However, I see one "dark spot" in this acquisition. Merus's operating loss was $110.4 million in Q2, up 82.4% year-over-year, which will ultimately slow Genmab's EPS growth until at least 2028.
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Ameya Dravid is a postdoctoral researcher in Ankur Singh’s lab at Georgia Tech. In this postdoc portrait article, he ...
In today’s fast-moving world, health concerns are often pushed aside until symptoms become impossible to ignore. Unfortunately, when it comes to serious conditions like multiple myeloma, waiting can ...